4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-052310
Chairman and CEO bought 3,500 shares at an average $1.02 ($3,555)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-09-25 | Purchase | +1,000 | $1.03 | $1,030 | 10,686,246 | D |
| Niihara Yutaka Chairman and CEO | 2020-09-28 | Purchase | +2,500 | $1.01 | $2,525 | 10,688,746 | D |
| Open-market purchases · 3,500 sh · avg $1.02 · $3,555 | |||||||
Loading xslF345X03/doc4.xml…